An industry for healthy lives

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.

e-Library

Vaccines Europe papers and publications

From vaccines shortages to sustainable vaccine supply

 

Role of vaccination in reducing antimicrobial resistance

 

Reflection paper on the Safety Assessment of Residuals and Contaminants in Vaccines

 

Reply to the Green Paper on the modernisation of EU public procurement policy

 

Submission of comments on General Report on experience acquired as a result of the application of the paediatric regulation

 

Implementation of the EU Paediatric Regulation and its Impact on Vaccine Development – Issues and Proposals for Improvement

 

General report on experience acquired as a result of the application of the paediatric regulation

 

VE industry vision on future R&D

 

Adult_Vaccination Key Component of Healthy Ageing (SAATI Report)

 

Attitudes to Vaccination Critical Review

 

EFPIA VE IMI2 Strategic Research Agenda

 

NITAG policies in developed countries – Vaccine

 

Strengthening NITAG policies – Vaccine

 

Infographics

Vaccines: a tool for spending smart

 

Prevention First: Vaccination at Heart of Public Health

 

The impact of influenza vaccination in the European Union

 

How long for a vaccine to reach European population? A Vaccines Europe study

 

The Vaccines Industry in figures

 

Vaccines’ contribution to Europe’s future

 

Other resources (events, external materials, etc.)

OECD presentations on Investment in Prevention (2013)

 

GMAS presentation on Benefits of Adult Immunisation (2013)

 

Gallery of Vaccines Europe Day 2013 (flickr)